Navigation Links
Aeterna Zentaris Reports Third Quarter 2010 Financial and Operating Results
Date:11/9/2010

summaryInterim Consolidated Results of Operations
(in thousands, except for share and per share data)
(unaudited)

    Three months ended
September 30, Nine months ended
September 30,   2010 2009 2010 2009   $ $ $ $ Revenues Sales and royalties 5,463 5,539 16,344 15,937 License fees and other 263 3,026 1,388 7,118   5,726 8,565 17,732 23,055 Operating expenses Cost of sales, excluding depreciation and amortization 4,292 4,488 13,324 12,727 Research and development costs, net of tax credits and grants 4,061 9,738 14,791 33,251 Selling, general and administrative expenses 2,859 3,193 8,780 9,849 Depreciation and amortization   Property, plant and equipment 239 341 744 983   Intangible assets 363 594 1,110 1,714   11,814 18,354 38,749 58,524 Loss from operations (6,088) (9,789) (21,017) (35,469) Other income (expenses) Interest income 22 39 111 311 Foreign exchange (loss) gain (4,081) (1,538) 429 (1,598)   (4,059) (1,499) 540 (1,287) Net loss for the period (10,147) (11,288) (20,477) (36,756)   Net loss per share Basic and diluted (0.12) (0.19) (0.28) (0.67) Weighted average number of shares Basic and diluted 83,139,620 58,506,619 73,122,927 55,135,876 Interim Consolidated Balance Sheet Information
(in thousands)
(unaudited)   As atSeptember 30,2010 As
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
2. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
3. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
4. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
5. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
6. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
7. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
10. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
11. AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Memphis, TENN (PRWEB) December 22, 2014 ... with Donor Egg Bank USA , a network ... the country. Through this partnership, patients have fast access ... for in vitro fertilization, IVF . Fertility Associates of ... to offer this fertility treatment option. , Dr. ...
(Date:12/19/2014)... Charm Sciences is pleased to announce ... of Aflatoxin M1 in raw commingled milk is the ... validation. The peer reviewed report of the validation by ... Agricultural and Fisheries Research (ILVO-T&V) has been published by ... the most toxic aflatoxin and a known carcinogen, can ...
(Date:12/19/2014)... Naurex Inc., a biopharmaceutical company leveraging its ... the central nervous system, today announced that Norbert ... present at the 33 rd annual J.P. Morgan ... 3:00 p.m. PST on Tuesday, January 13, 2015, at ... Calif. About Naurex Inc. ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... for In-Vitro / In-Vivo ... Correlation Modeling in Drug Development, MOUNTAIN VIEW, ... a leading provider of software, strategic,consulting, and regulatory services ... MS, Director of,Training and Pre-Sales, will speak to members ...
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on ... request a hearing before The NASDAQ Listing,Qualifications Panel ... delist the Company,s common stock from The NASDAQ ... The NASDAQ Stock Market ("NASDAQ") on,June 17, 2008 ...
... 2008 / b3c newswire /  - Rentschler ... biopharmazeutischer Arzneimittel gibt die Inbetriebnahme einer 2.500 ... nun über neun unabhängige GMP-Produktionslinien mit Arbeitsvolumen ... für die Herstellung von klinischen Prüfmustern und ...
Cached Biology Technology:Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 2Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 3Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination 2Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen 2
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... domain . . . With the ... National Laboratory,s Center for Nanophase Materials Sciences, scientists ... open new pathways for nanoscale electronics. The study, ... ) and led by Ramamoorthy Ramesh of Lawrence ...
... avoid creating greenhouse gases, it makes more sense using ... reserves than to plow it up for corn to ... "Converting set-asides to corn-ethanol production is an inefficient ... be encouraged until ethanol-production technologies improve," the study,s authors ...
... ongoing mission to train and educate scientists on the ... Craig Venter Institute,s (JCVI) Eukaryotic Genome Annotation and Analysis ... train 40 United States Agriculture Department (USDA) scientists at ... will focus on the use of JCVI,s eukaryotic annotation ...
Cached Biology News:Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 2Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 3Study critiques corn-for-ethanol's carbon footprint 2Study critiques corn-for-ethanol's carbon footprint 3JCVI program trains USDA scientists on eukaryotic genome analysis 2
... Assay Kits are ideal for studying or ... GR Competitor Assay Kits contain partially purified ... of the following proprietary fluorescent glucocorticoid Fluormone ... (red assay kit), or GS Far Red ...
... complete kit contains enough separation ... a total of 5 x ... includes the StemSep red magnet ... and buffers for the specific ...
... * Source rat ... T25 plated cells $550.00, * ... 120 population doublings, * This ... complete ,growth medium M55007-08 and ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
Biology Products: